$MOH

Molina Healthcare Inc (MOH) (Q3 2026) Earnings Call Highlights: Reaffirmed Guidance

Molina Healthcare (MOH) reported Q3 2026 adjusted pre-tax margin of 0.6% and reaffirmed guidance. Medicaid cost trend rose to 5.5%, and new contracts in Georgia/Texas were delayed. Marketplace and Medicare MAPD segments are expected to lose $0.75 and $1 per share, respectively, in 2026. CEO Joe Zubretsky and CFO Mark Keim discussed Medicaid MLR improvements, Florida CMS contract, and enrollment declines.

Original reporting
Published Oct 22, 2026, 11:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 11:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Molina Healthcare Inc (MOH) (Q3 2026) Earnings Call Highlights: Reaffirmed Guidance — source image
Decision brief

The 30-second read

$MOHBearishMed
01

Why it matters

The disclosed low margins and delayed contracts suggest near‑term earnings pressure, but management cites rate updates and cost improvements for Q4.

02

Market read

Guidance shortfall may trigger a sell‑off in MOH and influence sentiment toward similar health‑care insurers.

03

What to watch

Potential upside from cost‑control measures and G&A improvements mentioned for Q4 could mitigate margin weakness.

Relevance 7/10Novelty 7/10Timing: post‑earnings today

Background

Molina Healthcare provided its Q3 2026 earnings call, reaffirming guidance and outlining operational challenges.

Company-level read

Ticker impact

$MOHBearishHigh confidence
Context

Earnings call disclosed low adjusted pre‑tax margin of 0.6% in Q3 2026, delayed $1.3 B Medicaid contracts and projected losses in Marketplace and Medicare MAPD segments.

Expected impact

downward pressure as investors price in lower margins and contract delays

Evidence & confidence

Margins are near break‑even and significant revenue is pushed to 2027‑28; guidance loss per share signals earnings shortfall.

Market effects

Highlights pressure on Medicaid‑focused insurers and may affect peer health‑maintenance organization stocks.

Potential downside for U.S. health‑care sector indices.

Limited to U.S. health‑care market; no broader macro impact.

Counterpoint

If Medicaid enrollment stabilizes faster than expected, the delayed contracts could boost future earnings, offering a buying opportunity at depressed prices.

Key entities

  • Molina Healthcare Inc.

    U.S. Medicaid and Medicare insurer.

  • Joe Zubretsky

    CEO of Molina Healthcare.

  • Mark Keim

    CFO of Molina Healthcare.

Related articles

$MOHHighAI 8/10

Molina Healthcare Q3 Earnings Call Highlights

Molina Healthcare (MOH) expects its legacy Medicaid business to achieve a 1.6% pretax margin in 2026, with a 6% rate increase projected for 2027. The company anticipates a 6% membership decline in 2027 due to federal work requirements. Its Florida CMS contract, started in Q3, is expected to create a $1.50-per-share earnings drag in 2026. Molina's 2027 premium revenue is projected at $45 billion, down from $46.5 billion. The company's Medicare and Marketplace segments show mixed performance.

$MOHHighAI 8/10

Molina Healthcare (MOH) Q3 2026 Earnings Call Transcript

Molina Healthcare (MOH) reported Q3 2026 adjusted EPS of $0.89B on $10.5B premium revenue, with a 92.9% MCR. Full-year 2026 guidance remains $42B in premium revenue and at least $5.25 EPS. 2027 premium revenue is expected to be at least $45B, with known rate increases averaging 6% and medical cost trend projected at 5.5%-6%. The company reaffirmed its Medicaid and Medicare strategies, including exiting the MAPD business and reducing Marketplace footprint.

$MOHHighAI 8/10

Molina: Q3 Earnings Snapshot

Molina Healthcare (MOH) reported Q3 net income of $38M, or 73 cents per share, beating analyst estimates of 72 cents. Revenue was $11.08B, exceeding expectations of $10.93B. The company forecasts full-year earnings of $5.25 per share and revenue of $42B.

$MOHHighAI 8/10

Molina Healthcare’s (NYSE:MOH) Q3 2026 sales top estimates

Molina Healthcare (MOH) reported Q3 2026 revenue of $11.08B, down 3.4% YoY but exceeding estimates by 2%. Adjusted operating margin was 1.2%, and EPS was $0.89, down from last year but beating estimates. Analysts project 9% revenue growth and 311% EPS growth over the next 12 months. The stock fell 4.1% post-results.